Celltex Therapeutics Corporation, a major sponsor of the "Regenerative Medicine 2.0: Redefining the Practice" Conference, presents award June 25, 2016
June 23, 2016 (Newswire.com) - Regenera Global announces its collaboration with Houston-based biotechnology company, Celltex Therapeutics Corporation, as the sponsor for the newly-created 2016 Celltex Outstanding Investigator Award. Regenera Global recognizes the forward thinking and leadership of Celltex Therapeutics as a premier provider of stem cell banking services in the United States. The award will be presented by Celltex Chairman and CEO, David Eller, at the Regenera Global Conference entitled, "Regenerative Medicine 2.0: Redefining the Practice". The presentation will take place Saturday, June 25, 2016 at the Grand Lucayan in Freeport, Grand Bahama.
Regenera Global will serve as the administrator for the annual award which recognizes an investigator whose novel and significant work has had or may have a far-reaching impact on the clinical translation of regenerative medicine for health or anti-aging applications. Such work may involve any discipline across the continuum of biomedical research that remains in the parameters of basic, translational or clinical studies.
The recipient of the 2016 Celltex Outstanding Investigator Award will be publically recognized for his/her outstanding work and will receive a $1,000 unrestricted cash award.
"Celltex is proud to collaborate with Regenera Global in the creation of the 2016 Celltex Outstanding Investigator award," Eller says. "In recognizing the contributions of a deserving researcher, we continue to propel the advancement of regenerative medicine at a time when 21st Century Cures are greatly needed."
Applications for the 2017 Celltex Outstanding Investigator Award will be available from Regenera Global beginning August 1, 2016. Registration information for the conference may be found at regeneraglobal.com.
About Celltex Therapeutics Corporation
Celltex is a Houston-based biotechnology company that is leading the United States into the future of regenerative medicine with its proprietary technology that isolates, multiplies and stores autologous, adult, adipose (fat tissue)-derived mesenchymal stem cells (MSCs) to be used for regenerative therapy in a number of conditions including vascular, autoimmune and degenerative diseases. Celltex is committed to expanding the use of adult stem cell therapy for all and is currently working with leading American academic institutions on several clinical trials that will help secure the future of regenerative medicine here in the United States. For more information about Celltex Therapeutics Corporation, please visit celltexbank.com.
About Regenera Global, Inc.
Based in Puerto Rico, Regenera Global, Inc. is a bio-technology firm focused on developing and commercializing innovative therapies, providing consulting services and educational events to physicians and healthcare practitioners to expand their knowledge of regenerative medicine clinical applications which may include, but is not limited to, stem cell and gene therapy, tissue engineering, and select medical devices. Regenera Global is working to bridge the gap of access to regenerative medicine between the progress made through research and what is available clinically to physicians and patients.